speb/financial-data huggingface dataset:
CVEO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 346198000.00
CVEO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 218091000.00
CVEO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 218091000.00
CVEO income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 4115000.00
CVEO income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -135000.00
CVEO balance_sheet (annual, 2025-12-31) — Total Tax Payable: 4026000.00
CVEO balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 4026000.00
CVEO income_statement (annual, 2025-12-31) — Total Unusual Items: 0.00
CVEO income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
CVEO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CVEO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CVEO balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 437995.00
CVEO balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 437995.00
CVEO balance_sheet (annual, 2025-12-31) — Treasury Stock: 10775000.00
CVEO balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 10775000.00
CVEO balance_sheet (annual, 2025-12-31) — Working Capital: 46277000.00
CVEO balance_sheet (quarterly, 2025-12-31) — Working Capital: 46277000.00
CVEO income_statement (quarterly, 2026-03-31) — +Operating Expense: 37038000.00
CVEO income_statement (quarterly, 2026-03-31) — +Total Revenue: 172667000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 44654000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 88509000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -1315177000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 1635135000.00
CVEO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 11122000.00
CVEO income_statement (quarterly, 2026-03-31) — Basic EPS: -0.34
CVEO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 14439000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 14053000.00
CVEO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -4133000.00
CVEO cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -4133000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 14040000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 0.00
CVEO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 16549000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 16549000.00
CVEO cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: 0.00
CVEO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 15868000.00
CVEO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -3933000.00
CVEO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -9744000.00
CVEO cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -4108000.00
CVEO cash_flow (quarterly, 2026-03-31) — Change In Income Tax Payable: -2332000.00
CVEO cash_flow (quarterly, 2026-03-31) — Change In Inventory: -17000.00
CVEO cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -2417000.00
CVEO cash_flow (quarterly, 2026-03-31) — Change In Payable: -6440000.00
CVEO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -6440000.00
CVEO cash_flow (quarterly, 2026-03-31) — Change In Receivables: -15992000.00
CVEO cash_flow (quarterly, 2026-03-31) — Change In Tax Payable: -2332000.00
CVEO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -24866000.00
CVEO cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -15992000.00
CVEO cash_flow (quarterly, 2026-03-31) — Changes In Cash: 2191000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Common Stock: 0.00
CVEO cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: 0.00
CVEO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 160746000.00
CVEO cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -14353000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 3482000.00
CVEO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 132506000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 1050000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Current Assets: 152823000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 2806000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 2806000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 81074000.00
CVEO cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -139000.00
CVEO cash_flow (quarterly, 2026-03-31) — Deferred Tax: -139000.00
CVEO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 17308000.00
CVEO income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 17308000.00
CVEO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 17308000.00
CVEO income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 17308000.00
CVEO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 11122000.00
CVEO income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.34
CVEO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -3808000.00
CVEO income_statement (quarterly, 2026-03-31) — EBIT: 3100000.00
CVEO income_statement (quarterly, 2026-03-31) — EBITDA: 20408000.00
CVEO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -81000.00
CVEO cash_flow (quarterly, 2026-03-31) — End Cash Position: 16549000.00
CVEO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 15868000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Finished Goods: 4513000.00
CVEO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -13877000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -385918000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Goodwill: 7774000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 76003000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Gross PPE: 1568149000.00
CVEO income_statement (quarterly, 2026-03-31) — Gross Profit: 40161000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 182000.00
CVEO income_statement (quarterly, 2026-03-31) — Interest Expense: 3762000.00
CVEO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 3762000.00
CVEO income_statement (quarterly, 2026-03-31) — Interest Income: 38000.00
CVEO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 38000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Inventory: 6337000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 373022000.00
CVEO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -3933000.00
CVEO cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 192837000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 29881000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 14040000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 212276000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 226316000.00
CVEO cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 192837000.00
CVEO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -162279000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 93668000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Minority Interest: 0.00
CVEO income_statement (quarterly, 2026-03-31) — Minority Interests: -5000.00
CVEO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -14353000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Net Debt: 195727000.00
CVEO income_statement (quarterly, 2026-03-31) — Net Income: -3808000.00
CVEO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -3808000.00
CVEO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -3803000.00
CVEO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -3808000.00
CVEO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -3808000.00
CVEO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -3803000.00
CVEO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -3803000.00
CVEO income_statement (quarterly, 2026-03-31) — Net Interest Income: -3724000.00
CVEO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 30558000.00
CVEO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 30558000.00
CVEO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -3724000.00
CVEO cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -337000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Net PPE: 252972000.00
CVEO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 200000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 84743000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 3272000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 3272000.00
CVEO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 20408000.00
CVEO income_statement (quarterly, 2026-03-31) — Normalized Income: -3808000.00
CVEO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -9744000.00
CVEO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -19000.00
CVEO income_statement (quarterly, 2026-03-31) — Operating Income: 3123000.00
CVEO income_statement (quarterly, 2026-03-31) — Operating Revenue: 172667000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 10943296.00
CVEO balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 2656000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 7181000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -385918000.00
CVEO income_statement (quarterly, 2026-03-31) — Other Income Expense: -61000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 68229000.00
CVEO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 661000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 9807000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 20197000.00
CVEO income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -61000.00
CVEO income_statement (quarterly, 2026-03-31) — Other Operating Expenses: -338000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Other Properties: 1427065000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Other Receivables: 19741000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Payables: 48880000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 49930000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 21157000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 20115000.00
CVEO income_statement (quarterly, 2026-03-31) — Pretax Income: -662000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
CVEO cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 862000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Raw Materials: 1824000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Receivables: 107166000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Receivables Adjustments Allowances: -1084000.00
CVEO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 132506000.00
CVEO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 17308000.00
CVEO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -162279000.00
CVEO cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -14353000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -1077359000.00
CVEO cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 200000.00
CVEO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 20068000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Share Issued: 11393480.00
CVEO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 252000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 160746000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 84743000.00
CVEO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CVEO income_statement (quarterly, 2026-03-31) — Tax Provision: 3141000.00
CVEO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
CVEO balance_sheet (quarterly, 2026-03-31) — Total Assets: 491605000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 373022000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Total Debt: 226316000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 160746000.00
CVEO income_statement (quarterly, 2026-03-31) — Total Expenses: 169544000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 330859000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 338782000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 249785000.00
CVEO income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 3123000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 4226000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 450184.00
CVEO balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 11112000.00
CVEO balance_sheet (quarterly, 2026-03-31) — Working Capital: 71749000.00
CVG.TO income_statement (annual, 2022-03-31) — +Operating Expense: 40228000.00
CVG.TO income_statement (annual, 2022-03-31) — +Total Revenue: 415241000.00
CVG.TO balance_sheet (annual, 2022-03-31) — Accounts Payable: 6852000.00
CVG.TO balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -4471000.00
CVG.TO balance_sheet (annual, 2022-03-31) — Available For Sale Securities: 130378000.00
CVG.TO income_statement (annual, 2022-03-31) — Basic Average Shares: 15055594.00
CVG.TO income_statement (annual, 2022-03-31) — Basic EPS: 21.93
CVG.TO cash_flow (annual, 2022-03-31) — Beginning Cash Position: 186795000.00
CVG.TO cash_flow (annual, 2022-03-31) — Capital Expenditure: -466000.00
CVG.TO balance_sheet (annual, 2022-03-31) — Capital Stock: 80794000.00
CVG.TO balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 218417000.00
CVG.TO balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Federal Funds Sold: 218417000.00
CVG.TO cash_flow (annual, 2022-03-31) — Cash Dividends Paid: -8577000.00
CVG.TO balance_sheet (annual, 2022-03-31) — Cash Equivalents: 13118000.00
CVG.TO balance_sheet (annual, 2022-03-31) — Cash Financial: 205299000.00
CVG.TO cash_flow (annual, 2022-03-31) — Change In Accrued Expense: 8091000.00
CVG.TO cash_flow (annual, 2022-03-31) — Change In Other Current Liabilities: 0.00
CVG.TO cash_flow (annual, 2022-03-31) — Change In Payable: -2318000.00
CVG.TO cash_flow (annual, 2022-03-31) — Change In Receivables: -20672000.00
CVG.TO cash_flow (annual, 2022-03-31) — Change In Working Capital: -14899000.00
CVG.TO cash_flow (annual, 2022-03-31) — Changes In Cash: 31622000.00
CVG.TO balance_sheet (annual, 2022-03-31) — Common Stock: 80794000.00
CVG.TO cash_flow (annual, 2022-03-31) — Common Stock Dividend Paid: -8577000.00
CVG.TO balance_sheet (annual, 2022-03-31) — Common Stock Equity: 1179087000.00
CVG.TO cash_flow (annual, 2022-03-31) — Common Stock Payments: -350000.00
CVG.TO cash_flow (annual, 2022-03-31) — Depreciation: 1144000.00
CVG.TO cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 1144000.00
CVG.TO balance_sheet (annual, 2022-03-31) — Derivative Product Liabilities: 0.00
CVG.TO income_statement (annual, 2022-03-31) — Diluted Average Shares: 15055594.00
CVG.TO income_statement (annual, 2022-03-31) — Diluted EPS: 21.93
CVG.TO income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: 330207000.00
CVG.TO cash_flow (annual, 2022-03-31) — Dividend Received Cfo: 82603000.00
CVG.TO cash_flow (annual, 2022-03-31) — End Cash Position: 218417000.00
CVG.TO balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 849073000.00
CVG.TO cash_flow (annual, 2022-03-31) — Financing Cash Flow: -8927000.00
CVG.TO cash_flow (annual, 2022-03-31) — Free Cash Flow: 40549000.00
CVG.TO cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: -436585000.00
CVG.TO income_statement (annual, 2022-03-31) — General And Administrative Expense: 4322000.00
CVG.TO balance_sheet (annual, 2022-03-31) — Gross PPE: 11766000.00
CVG.TO income_statement (annual, 2022-03-31) — Interest Expense: 705000.00
CVG.TO income_statement (annual, 2022-03-31) — Interest Income: 119486000.00
CVG.TO cash_flow (annual, 2022-03-31) — Investing Cash Flow: -466000.00
CVG.TO balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 982673000.00
CVG.TO balance_sheet (annual, 2022-03-31) — Investments And Advances: 1018169000.00
CVG.TO balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 35496000.00
CVG.TO cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: -350000.00
CVG.TO income_statement (annual, 2022-03-31) — Net Income: 330207000.00
CVG.TO income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 330207000.00
CVG.TO income_statement (annual, 2022-03-31) — Net Income Continuous Operations: 330207000.00
CVG.TO income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 330207000.00
CVG.TO income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 330207000.00
CVG.TO cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: 330207000.00
CVG.TO income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: 330207000.00
CVG.TO income_statement (annual, 2022-03-31) — Net Interest Income: 118781000.00
CVG.TO cash_flow (annual, 2022-03-31) — Net Other Financing Charges: 0.00
CVG.TO balance_sheet (annual, 2022-03-31) — Net PPE: 7295000.00
CVG.TO cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -466000.00
CVG.TO balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 1179087000.00
CVG.TO income_statement (annual, 2022-03-31) — Normalized Income: 330207000.00
CVG.TO cash_flow (annual, 2022-03-31) — Operating Cash Flow: 41015000.00
CVG.TO income_statement (annual, 2022-03-31) — Operating Revenue: 415241000.00
CVG.TO balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 15052301.00
CVG.TO cash_flow (annual, 2022-03-31) — Other Non Cash Items: 56603000.00
CVG.TO balance_sheet (annual, 2022-03-31) — Payables: 7192000.00
CVG.TO income_statement (annual, 2022-03-31) — Pretax Income: 375013000.00
CVG.TO cash_flow (annual, 2022-03-31) — Purchase Of PPE: -466000.00
CVG.TO balance_sheet (annual, 2022-03-31) — Receivables: 104282000.00
CVG.TO income_statement (annual, 2022-03-31) — Reconciled Depreciation: 1144000.00
CVG.TO cash_flow (annual, 2022-03-31) — Repurchase Of Capital Stock: -350000.00
CVG.TO balance_sheet (annual, 2022-03-31) — Retained Earnings: 1098293000.00
CVG.TO income_statement (annual, 2022-03-31) — Selling General And Administration: 4322000.00
CVG.TO balance_sheet (annual, 2022-03-31) — Share Issued: 15052301.00
CVG.TO balance_sheet (annual, 2022-03-31) — Stockholders Equity: 1179087000.00
CVG.TO balance_sheet (annual, 2022-03-31) — Tangible Book Value: 1179087000.00
CVG.TO income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 0.00
CVG.TO income_statement (annual, 2022-03-31) — Tax Provision: 44806000.00
CVG.TO income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.12
CVG.TO balance_sheet (annual, 2022-03-31) — Taxes Receivable: 4980000.00
CVG.TO balance_sheet (annual, 2022-03-31) — Total Assets: 1353143000.00
CVG.TO balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 1179087000.00
CVG.TO balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 174056000.00
CVG.TO balance_sheet (annual, 2022-03-31) — Total Tax Payable: 340000.00
CVG.TO income_statement (annual, 2023-03-31) — +Operating Expense: 55442000.00
CVG.TO income_statement (annual, 2023-03-31) — +Total Revenue: 119126000.00
CVG.TO balance_sheet (annual, 2023-03-31) — Accounts Payable: 13834000.00
CVG.TO balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -5641000.00
CVG.TO balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 61661000.00
CVG.TO income_statement (annual, 2023-03-31) — Basic Average Shares: 15036381.00
CVG.TO income_statement (annual, 2023-03-31) — Basic EPS: 3.48
CVG.TO cash_flow (annual, 2023-03-31) — Beginning Cash Position: 218417000.00
CVG.TO cash_flow (annual, 2023-03-31) — Capital Expenditure: -452000.00
CVG.TO balance_sheet (annual, 2023-03-31) — Capital Stock: 80642000.00
CVG.TO balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 217870000.00
CVG.TO balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Federal Funds Sold: 217870000.00
CVG.TO cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -11789000.00
CVG.TO balance_sheet (annual, 2023-03-31) — Cash Equivalents: 1676000.00
CVG.TO balance_sheet (annual, 2023-03-31) — Cash Financial: 216194000.00
CVG.TO cash_flow (annual, 2023-03-31) — Change In Accrued Expense: -1574000.00
CVG.TO cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 0.00
CVG.TO cash_flow (annual, 2023-03-31) — Change In Payable: 31843000.00
CVG.TO cash_flow (annual, 2023-03-31) — Change In Receivables: -5262000.00
CVG.TO cash_flow (annual, 2023-03-31) — Change In Working Capital: 25007000.00
CVG.TO cash_flow (annual, 2023-03-31) — Changes In Cash: -547000.00
CVG.TO balance_sheet (annual, 2023-03-31) — Common Stock: 80642000.00
CVG.TO cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -11789000.00
CVG.TO balance_sheet (annual, 2023-03-31) — Common Stock Equity: 1217727000.00
CVG.TO cash_flow (annual, 2023-03-31) — Common Stock Payments: -1940000.00
CVG.TO cash_flow (annual, 2023-03-31) — Depreciation: 1170000.00
CVG.TO cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 1170000.00
CVG.TO balance_sheet (annual, 2023-03-31) — Derivative Product Liabilities: 7077000.00
CVG.TO income_statement (annual, 2023-03-31) — Diluted Average Shares: 15036381.00
CVG.TO income_statement (annual, 2023-03-31) — Diluted EPS: 3.48
CVG.TO income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 52369000.00
CVG.TO cash_flow (annual, 2023-03-31) — Dividend Received Cfo: 0.00
CVG.TO cash_flow (annual, 2023-03-31) — End Cash Position: 217870000.00
CVG.TO balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1003010000.00
CVG.TO cash_flow (annual, 2023-03-31) — Financing Cash Flow: -13729000.00
CVG.TO cash_flow (annual, 2023-03-31) — Free Cash Flow: 13182000.00
CVG.TO cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -75032000.00
CVG.TO income_statement (annual, 2023-03-31) — General And Administrative Expense: 11368000.00
CVG.TO balance_sheet (annual, 2023-03-31) — Gross PPE: 12218000.00
CVG.TO income_statement (annual, 2023-03-31) — Interest Income: 29964000.00
CVG.TO cash_flow (annual, 2023-03-31) — Investing Cash Flow: -452000.00
CVG.TO balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 1064671000.00
CVG.TO balance_sheet (annual, 2023-03-31) — Investments And Advances: 1113985000.00
CVG.TO balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 49314000.00
CVG.TO cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: -1940000.00
CVG.TO income_statement (annual, 2023-03-31) — Net Income: 52369000.00
CVG.TO income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 52369000.00
CVG.TO income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 52369000.00
CVG.TO income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 52369000.00
CVG.TO income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 52369000.00
CVG.TO cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 52369000.00
CVG.TO income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 52369000.00
CVG.TO income_statement (annual, 2023-03-31) — Net Interest Income: 29964000.00
CVG.TO cash_flow (annual, 2023-03-31) — Net Other Financing Charges: 0.00
CVG.TO balance_sheet (annual, 2023-03-31) — Net PPE: 6577000.00
CVG.TO cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -452000.00
CVG.TO balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 1217727000.00
CVG.TO income_statement (annual, 2023-03-31) — Normalized Income: 52369000.00
CVG.TO cash_flow (annual, 2023-03-31) — Operating Cash Flow: 13634000.00
CVG.TO income_statement (annual, 2023-03-31) — Operating Revenue: 119126000.00
CVG.TO balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 15024001.00
CVG.TO cash_flow (annual, 2023-03-31) — Other Non Cash Items: 3132000.00
CVG.TO balance_sheet (annual, 2023-03-31) — Payables: 39035000.00
CVG.TO income_statement (annual, 2023-03-31) — Pretax Income: 63684000.00
CVG.TO cash_flow (annual, 2023-03-31) — Purchase Of PPE: -452000.00
CVG.TO balance_sheet (annual, 2023-03-31) — Receivables: 90077000.00
CVG.TO income_statement (annual, 2023-03-31) — Reconciled Depreciation: 1170000.00
CVG.TO cash_flow (annual, 2023-03-31) — Repurchase Of Capital Stock: -1940000.00
CVG.TO balance_sheet (annual, 2023-03-31) — Retained Earnings: 1137085000.00
CVG.TO income_statement (annual, 2023-03-31) — Selling General And Administration: 11368000.00
CVG.TO balance_sheet (annual, 2023-03-31) — Share Issued: 15024001.00
CVG.TO balance_sheet (annual, 2023-03-31) — Stockholders Equity: 1217727000.00
CVG.TO balance_sheet (annual, 2023-03-31) — Tangible Book Value: 1217727000.00
CVG.TO income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 0.00
CVG.TO income_statement (annual, 2023-03-31) — Tax Provision: 11315000.00
CVG.TO income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.18
CVG.TO balance_sheet (annual, 2023-03-31) — Taxes Receivable: 1142000.00
CVG.TO balance_sheet (annual, 2023-03-31) — Total Assets: 1429651000.00
CVG.TO balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 1217727000.00
CVG.TO balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 211924000.00
CVG.TO balance_sheet (annual, 2023-03-31) — Total Tax Payable: 25201000.00
CVG.TO income_statement (annual, 2024-03-31) — +Operating Expense: 32984000.00
CVG.TO income_statement (annual, 2024-03-31) — +Total Revenue: 29811000.00
CVG.TO balance_sheet (annual, 2024-03-31) — Accounts Payable: 16232000.00
CVG.TO balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -6947000.00
CVG.TO balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 104856000.00
CVG.TO income_statement (annual, 2024-03-31) — Basic Average Shares: 14861171.00
CVG.TO income_statement (annual, 2024-03-31) — Basic EPS: -0.23
CVG.TO cash_flow (annual, 2024-03-31) — Beginning Cash Position: 217870000.00
CVG.TO cash_flow (annual, 2024-03-31) — Capital Expenditure: -854000.00
CVG.TO balance_sheet (annual, 2024-03-31) — Capital Stock: 78762000.00
CVG.TO balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 145138000.00
CVG.TO balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Federal Funds Sold: 145138000.00
CVG.TO cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -12177000.00
CVG.TO balance_sheet (annual, 2024-03-31) — Cash Equivalents: 837000.00
CVG.TO balance_sheet (annual, 2024-03-31) — Cash Financial: 144301000.00
CVG.TO cash_flow (annual, 2024-03-31) — Change In Accrued Expense: -2443000.00
CVG.TO cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 0.00
CVG.TO cash_flow (annual, 2024-03-31) — Change In Payable: -22803000.00
CVG.TO cash_flow (annual, 2024-03-31) — Change In Receivables: -2436000.00
CVG.TO cash_flow (annual, 2024-03-31) — Change In Working Capital: -27682000.00
CVG.TO cash_flow (annual, 2024-03-31) — Changes In Cash: -72732000.00
CVG.TO balance_sheet (annual, 2024-03-31) — Common Stock: 78762000.00
CVG.TO cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -12177000.00
CVG.TO balance_sheet (annual, 2024-03-31) — Common Stock Equity: 1176297000.00
CVG.TO cash_flow (annual, 2024-03-31) — Common Stock Payments: -25900000.00
CVG.TO cash_flow (annual, 2024-03-31) — Depreciation: 1306000.00
CVG.TO cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 1306000.00
CVG.TO balance_sheet (annual, 2024-03-31) — Derivative Product Liabilities: 2622000.00
CVG.TO income_statement (annual, 2024-03-31) — Diluted Average Shares: 14861171.00
CVG.TO income_statement (annual, 2024-03-31) — Diluted EPS: -0.23
CVG.TO income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: -3353000.00
CVG.TO cash_flow (annual, 2024-03-31) — Dividend Received Cfo: 36014000.00
CVG.TO cash_flow (annual, 2024-03-31) — End Cash Position: 145138000.00
CVG.TO balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 950859000.00
CVG.TO cash_flow (annual, 2024-03-31) — Financing Cash Flow: -38077000.00
CVG.TO cash_flow (annual, 2024-03-31) — Free Cash Flow: -34655000.00
CVG.TO cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -30517000.00
CVG.TO income_statement (annual, 2024-03-31) — General And Administrative Expense: 3554000.00
CVG.TO balance_sheet (annual, 2024-03-31) — Gross PPE: 13072000.00
CVG.TO income_statement (annual, 2024-03-31) — Interest Expense: 9476000.00
CVG.TO income_statement (annual, 2024-03-31) — Interest Income: 3700000.00
CVG.TO cash_flow (annual, 2024-03-31) — Investing Cash Flow: -854000.00
CVG.TO balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 1055715000.00
CVG.TO balance_sheet (annual, 2024-03-31) — Investments And Advances: 1107903000.00
CVG.TO balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 52188000.00
CVG.TO cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: -25900000.00
CVG.TO income_statement (annual, 2024-03-31) — Net Income: -3353000.00
CVG.TO income_statement (annual, 2024-03-31) — Net Income Common Stockholders: -3353000.00
CVG.TO income_statement (annual, 2024-03-31) — Net Income Continuous Operations: -3353000.00
CVG.TO income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: -3353000.00
CVG.TO income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: -3353000.00
CVG.TO cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: -3353000.00
CVG.TO income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: -3353000.00
CVG.TO income_statement (annual, 2024-03-31) — Net Interest Income: -5776000.00
CVG.TO cash_flow (annual, 2024-03-31) — Net Other Financing Charges: 0.00
CVG.TO balance_sheet (annual, 2024-03-31) — Net PPE: 6125000.00
CVG.TO cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -854000.00
CVG.TO balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 1176297000.00
CVG.TO income_statement (annual, 2024-03-31) — Normalized Income: -3353000.00
CVG.TO cash_flow (annual, 2024-03-31) — Operating Cash Flow: -33801000.00
CVG.TO income_statement (annual, 2024-03-31) — Operating Revenue: 29811000.00
CVG.TO balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 14673701.00
CVG.TO cash_flow (annual, 2024-03-31) — Other Non Cash Items: -4651000.00
CVG.TO balance_sheet (annual, 2024-03-31) — Payables: 16232000.00
CVG.TO income_statement (annual, 2024-03-31) — Pretax Income: -3173000.00
CVG.TO cash_flow (annual, 2024-03-31) — Purchase Of PPE: -854000.00
CVG.TO balance_sheet (annual, 2024-03-31) — Receivables: 61477000.00
CVG.TO income_statement (annual, 2024-03-31) — Reconciled Depreciation: 1306000.00
CVG.TO cash_flow (annual, 2024-03-31) — Repurchase Of Capital Stock: -25900000.00
CVG.TO balance_sheet (annual, 2024-03-31) — Retained Earnings: 1097535000.00
CVG.TO income_statement (annual, 2024-03-31) — Selling General And Administration: 3554000.00
CVG.TO balance_sheet (annual, 2024-03-31) — Share Issued: 14673701.00
CVG.TO balance_sheet (annual, 2024-03-31) — Stockholders Equity: 1176297000.00
CVG.TO balance_sheet (annual, 2024-03-31) — Tangible Book Value: 1176297000.00
CVG.TO income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 0.00
CVG.TO income_statement (annual, 2024-03-31) — Tax Provision: 180000.00
CVG.TO income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.15
CVG.TO balance_sheet (annual, 2024-03-31) — Taxes Receivable: 21496000.00
CVG.TO balance_sheet (annual, 2024-03-31) — Total Assets: 1342139000.00
CVG.TO balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 1176297000.00
CVG.TO balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 165842000.00
CVG.TO balance_sheet (annual, 2024-03-31) — Total Tax Payable: 0.00
CVG.TO income_statement (quarterly, 2024-09-30) — Basic Average Shares: 14533582.00
CVG.TO income_statement (quarterly, 2024-09-30) — Basic EPS: 2.68
CVG.TO cash_flow (quarterly, 2024-09-30) — Capital Expenditure: -209000.00
CVG.TO cash_flow (quarterly, 2024-09-30) — Cash Dividends Paid: -11737000.00
CVG.TO cash_flow (quarterly, 2024-09-30) — Change In Accrued Expense: -2130000.00
CVG.TO cash_flow (quarterly, 2024-09-30) — Change In Payable: 1368000.00
CVG.TO cash_flow (quarterly, 2024-09-30) — Change In Receivables: 1954000.00
CVG.TO cash_flow (quarterly, 2024-09-30) — Common Stock Dividend Paid: -11737000.00
CVG.TO income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 14533582.00
CVG.TO income_statement (quarterly, 2024-09-30) — Diluted EPS: 2.68
CVG.TO income_statement (quarterly, 2024-09-30) — Interest Expense: 675000.00
CVG.TO balance_sheet (quarterly, 2024-09-30) — Trading Securities: 58849000.00
CVG.TO income_statement (quarterly, 2024-12-31) — +Operating Expense: 4950000.00
CVG.TO income_statement (quarterly, 2024-12-31) — +Total Revenue: 51280000.00
CVG.TO balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 14887000.00
CVG.TO balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -7998000.00
CVG.TO balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 56032000.00
CVG.TO income_statement (quarterly, 2024-12-31) — Basic Average Shares: 14240741.00
CVG.TO income_statement (quarterly, 2024-12-31) — Basic EPS: 2.70
CVG.TO cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 174844000.00
CVG.TO cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -105000.00
CVG.TO balance_sheet (quarterly, 2024-12-31) — Capital Stock: 76287000.00
CVG.TO balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 179302000.00
CVG.TO balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 179302000.00
CVG.TO cash_flow (quarterly, 2024-12-31) — Cash Dividends Paid: 0.00
CVG.TO balance_sheet (quarterly, 2024-12-31) — Cash Equivalents: 1472000.00
CVG.TO balance_sheet (quarterly, 2024-12-31) — Cash Financial: 177830000.00
CVG.TO cash_flow (quarterly, 2024-12-31) — Change In Accrued Expense: 1604000.00
CVG.TO cash_flow (quarterly, 2024-12-31) — Change In Other Current Liabilities: 0.00
CVG.TO cash_flow (quarterly, 2024-12-31) — Change In Payable: -602000.00
CVG.TO cash_flow (quarterly, 2024-12-31) — Change In Receivables: -2395000.00
CVG.TO cash_flow (quarterly, 2024-12-31) — Change In Working Capital: -1393000.00
CVG.TO cash_flow (quarterly, 2024-12-31) — Changes In Cash: 4458000.00
CVG.TO balance_sheet (quarterly, 2024-12-31) — Common Stock: 76287000.00
CVG.TO cash_flow (quarterly, 2024-12-31) — Common Stock Dividend Paid: 0.00
CVG.TO balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 1234349000.00
CVG.TO cash_flow (quarterly, 2024-12-31) — Common Stock Payments: -979000.00
CVG.TO cash_flow (quarterly, 2024-12-31) — Depreciation: 366000.00
CVG.TO cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 366000.00
CVG.TO balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 18176000.00
CVG.TO income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 14240741.00
CVG.TO income_statement (quarterly, 2024-12-31) — Diluted EPS: 2.70
CVG.TO income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 38450000.00
CVG.TO cash_flow (quarterly, 2024-12-31) — Dividend Received Cfo: 8139000.00
CVG.TO cash_flow (quarterly, 2024-12-31) — End Cash Position: 179302000.00
CVG.TO balance_sheet (quarterly, 2024-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 945036000.00
CVG.TO cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: -979000.00
CVG.TO cash_flow (quarterly, 2024-12-31) — Free Cash Flow: 5437000.00
CVG.TO cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: 442000.00
CVG.TO balance_sheet (quarterly, 2024-12-31) — Gross PPE: 13778000.00
CVG.TO income_statement (quarterly, 2024-12-31) — Interest Expense: -10402000.00
CVG.TO income_statement (quarterly, 2024-12-31) — Interest Income: 16261000.00
CVG.TO cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: -105000.00
CVG.TO balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 1053995000.00
CVG.TO balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 1102804000.00
CVG.TO balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 48809000.00
CVG.TO cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: -979000.00
CVG.TO income_statement (quarterly, 2024-12-31) — Net Income: 38450000.00
CVG.TO income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 38450000.00
CVG.TO income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 38450000.00
CVG.TO income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 38450000.00
CVG.TO income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 38450000.00
CVG.TO cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: 38450000.00
CVG.TO income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 38450000.00
CVG.TO income_statement (quarterly, 2024-12-31) — Net Interest Income: 16261000.00
CVG.TO cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: 0.00
CVG.TO balance_sheet (quarterly, 2024-12-31) — Net PPE: 5780000.00
CVG.TO cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -105000.00
CVG.TO balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 1234349000.00
CVG.TO income_statement (quarterly, 2024-12-31) — Normalized Income: 38450000.00
CVG.TO cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: 5542000.00
CVG.TO income_statement (quarterly, 2024-12-31) — Operating Revenue: 51280000.00
CVG.TO balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 14223531.00
CVG.TO cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: -37616000.00
CVG.TO balance_sheet (quarterly, 2024-12-31) — Payables: 14887000.00
CVG.TO income_statement (quarterly, 2024-12-31) — Pretax Income: 46330000.00
CVG.TO cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -105000.00
CVG.TO balance_sheet (quarterly, 2024-12-31) — Receivables: 113521000.00
CVG.TO income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 366000.00
CVG.TO cash_flow (quarterly, 2024-12-31) — Repurchase Of Capital Stock: -979000.00
CVG.TO balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 1158062000.00
CVG.TO balance_sheet (quarterly, 2024-12-31) — Share Issued: 14223531.00
CVG.TO balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 1234349000.00
CVG.TO balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 1234349000.00
CVG.TO income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CVG.TO income_statement (quarterly, 2024-12-31) — Tax Provision: 7880000.00
CVG.TO income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.17
CVG.TO balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 7251000.00
CVG.TO balance_sheet (quarterly, 2024-12-31) — Total Assets: 1408658000.00
CVG.TO balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 1234349000.00
CVG.TO balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 174309000.00
CVG.TO balance_sheet (quarterly, 2024-12-31) — Trading Securities: 52927000.00
CVG.TO income_statement (annual, 2025-03-31) — +Operating Expense: 32232000.00
CVG.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 11259000.00
CVG.TO income_statement (annual, 2025-03-31) — +Total Revenue: 170773000.00
CVG.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 32045000.00
CVG.TO balance_sheet (annual, 2025-03-31) — Accounts Payable: 12724000.00
CVG.TO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 12724000.00
CVG.TO balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -8352000.00
CVG.TO balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -8352000.00
CVG.TO balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 81962000.00
CVG.TO balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 81962000.00
CVG.TO income_statement (annual, 2025-03-31) — Basic Average Shares: 14410245.00
CVG.TO income_statement (annual, 2025-03-31) — Basic EPS: 8.47
CVG.TO cash_flow (annual, 2025-03-31) — Beginning Cash Position: 145138000.00
CVG.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 179302000.00
CVG.TO cash_flow (annual, 2025-03-31) — Capital Expenditure: -938000.00
CVG.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -232000.00
CVG.TO balance_sheet (annual, 2025-03-31) — Capital Stock: 76020000.00
CVG.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 76020000.00
CVG.TO balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 176978000.00
CVG.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 176978000.00
CVG.TO balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 176978000.00
CVG.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 176978000.00
CVG.TO cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -11737000.00
CVG.TO cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: 0.00
CVG.TO balance_sheet (annual, 2025-03-31) — Cash Equivalents: 3664000.00
CVG.TO balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 3664000.00
CVG.TO balance_sheet (annual, 2025-03-31) — Cash Financial: 173314000.00
CVG.TO balance_sheet (quarterly, 2025-03-31) — Cash Financial: 173314000.00
CVG.TO cash_flow (annual, 2025-03-31) — Change In Accrued Expense: 3613000.00
CVG.TO cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 0.00
CVG.TO cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 8603000.00
CVG.TO cash_flow (annual, 2025-03-31) — Change In Payable: -7085000.00
CVG.TO cash_flow (annual, 2025-03-31) — Change In Receivables: -18366000.00
CVG.TO cash_flow (annual, 2025-03-31) — Change In Working Capital: -21838000.00
CVG.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -13235000.00
CVG.TO cash_flow (annual, 2025-03-31) — Changes In Cash: 31840000.00
CVG.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -2324000.00
CVG.TO balance_sheet (annual, 2025-03-31) — Common Stock: 76020000.00
CVG.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 76020000.00
CVG.TO cash_flow (annual, 2025-03-31) — Common Stock Dividend Paid: -11737000.00
CVG.TO cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: 0.00
CVG.TO balance_sheet (annual, 2025-03-31) — Common Stock Equity: 1251591000.00
CVG.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1251591000.00
CVG.TO cash_flow (annual, 2025-03-31) — Common Stock Payments: -35011000.00
CVG.TO cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -3479000.00
CVG.TO cash_flow (annual, 2025-03-31) — Depreciation: 1405000.00
CVG.TO cash_flow (quarterly, 2025-03-31) — Depreciation: 354000.00
CVG.TO cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 1405000.00
CVG.TO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 354000.00
CVG.TO balance_sheet (annual, 2025-03-31) — Derivative Product Liabilities: 18113000.00
CVG.TO balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 18113000.00
CVG.TO income_statement (annual, 2025-03-31) — Diluted Average Shares: 14410245.00
CVG.TO income_statement (annual, 2025-03-31) — Diluted EPS: 8.47
CVG.TO income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 122042000.00
CVG.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 20721000.00
CVG.TO cash_flow (annual, 2025-03-31) — Dividend Received Cfo: 15101000.00
CVG.TO cash_flow (quarterly, 2025-03-31) — Dividend Received Cfo: 291000.00
CVG.TO cash_flow (annual, 2025-03-31) — End Cash Position: 176978000.00
CVG.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 176978000.00
CVG.TO balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 979645000.00
CVG.TO balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 979645000.00
CVG.TO cash_flow (annual, 2025-03-31) — Financing Cash Flow: -46748000.00
CVG.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -3479000.00
CVG.TO cash_flow (annual, 2025-03-31) — Free Cash Flow: 78588000.00
CVG.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 1155000.00
CVG.TO cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: 3914000.00
CVG.TO cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -9190000.00
CVG.TO income_statement (annual, 2025-03-31) — General And Administrative Expense: 3341000.00
CVG.TO balance_sheet (annual, 2025-03-31) — Gross PPE: 20072000.00
CVG.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 20072000.00
CVG.TO income_statement (annual, 2025-03-31) — Interest Income: 43130000.00
CVG.TO income_statement (quarterly, 2025-03-31) — Interest Income: 36348000.00
CVG.TO cash_flow (annual, 2025-03-31) — Investing Cash Flow: -938000.00
CVG.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -232000.00
CVG.TO balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 1061607000.00
CVG.TO balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 1061607000.00
CVG.TO balance_sheet (annual, 2025-03-31) — Investments And Advances: 1110124000.00
CVG.TO balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 1110124000.00
CVG.TO balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 48517000.00
CVG.TO balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 48517000.00
CVG.TO cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: -35011000.00
CVG.TO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -3479000.00
CVG.TO income_statement (annual, 2025-03-31) — Net Income: 122042000.00
CVG.TO income_statement (quarterly, 2025-03-31) — Net Income: 20721000.00
CVG.TO income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 122042000.00
CVG.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 20721000.00
CVG.TO income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 122042000.00
CVG.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 20721000.00
CVG.TO income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 122042000.00
CVG.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 20721000.00
CVG.TO income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 122042000.00
CVG.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 20721000.00
CVG.TO cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 122042000.00
CVG.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 20721000.00